Skip to content

Effect of preemptive analgesia on analgesia of epidural labor

Effect of preemptive analgesia on analgesia of epidural labor

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026671
Enrollment
Unknown
Registered
2019-10-17
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labor

Interventions

1:Prefabricated epidural catheter
2:On-demand analgesia

Sponsors

Eastern Theater General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Subjects voluntarily signed the informed consent for this trial; 2. Aged 18-35 years; 3. Singleton, term, head pregnancy; 4. ASA class I-II; 5. Primipara; 6. Planned vaginal delivery; 7. Vaginal delivery can be assessed by an obstetrician.

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the inclusion criteria or who are considered by the anesthesiologist to be unfit to participate in the trial; 2. The labor process has begun to temporarily require epidural labor analgesia; 3. Those who suffer from allergic diseases and allergies; those who have a similar history of drug structure, have a history of allergies to narcotic drugs, and have a history of malignant hyperthermia; 4. Spinal deformity, inability to tolerate subarachnoid catheter placement; 5. The patient has contraindications for intrathecal puncture catheter surgery; 6. History of previous central nervous system infections; 7. Coagulopathy; 8. Subarachnoid obstruction; 9. Contraindications to the test drug; 10. Patients suspected of having or having a history of drug abuse; 11. History of past mental illness, including mental illness diagnosed before or during pregnancy; 12. Systemic infection, skin or soft tissue infection at the puncture site; 13. Other factors that the investigator considers inappropriate for participation in the study.

Design outcomes

Primary

MeasureTime frame
VAS score;

Countries

China

Contacts

Public ContactManlin Duan

Eastern Theater General Hospital

dml9001@nju.edu.cn+86 13705184501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026